CONNECT WITH US

Handa Pharmaceuticals aims for annual new drug launches with dual growth engines

, Taipei
0

Credit: DIGITIMES

Handa Pharmaceuticals is pursuing a dual-engine strategy focusing on the development of high-barrier/patentable generics and 505(b)(2) new drugs...

The article requires paid subscription. Subscribe Now